Douglass Winthrop Advisors LLC decreased its stake in Monster Beverage Co. (NASDAQ:MNST - Free Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,568,244 shares of the company's stock after selling 17,100 shares during the quarter. Monster Beverage accounts for about 1.6% of Douglass Winthrop Advisors LLC's portfolio, making the stock its 26th largest position. Douglass Winthrop Advisors LLC owned approximately 0.16% of Monster Beverage worth $82,427,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Migdal Insurance & Financial Holdings Ltd. increased its position in shares of Monster Beverage by 62.5% in the 4th quarter. Migdal Insurance & Financial Holdings Ltd. now owns 528 shares of the company's stock valued at $28,000 after buying an additional 203 shares in the last quarter. Spire Wealth Management bought a new stake in Monster Beverage during the 4th quarter worth approximately $29,000. Retirement Wealth Solutions LLC bought a new position in Monster Beverage in the fourth quarter valued at approximately $30,000. SBI Securities Co. Ltd. acquired a new position in shares of Monster Beverage in the fourth quarter valued at approximately $31,000. Finally, Geneos Wealth Management Inc. acquired a new stake in shares of Monster Beverage during the fourth quarter worth $33,000. Institutional investors own 72.36% of the company's stock.
Insider Buying and Selling at Monster Beverage
In other Monster Beverage news, insider Emelie Tirre sold 91,316 shares of the stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $55.38, for a total transaction of $5,057,080.08. Following the transaction, the insider now owns 76,201 shares in the company, valued at $4,220,011.38. This represents a 54.51 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Thomas J. Kelly sold 10,000 shares of Monster Beverage stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $55.27, for a total transaction of $552,700.00. Following the completion of the sale, the chief financial officer now owns 72,273 shares of the company's stock, valued at approximately $3,994,528.71. The trade was a 12.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 208,316 shares of company stock valued at $11,484,440 in the last ninety days. 7.80% of the stock is currently owned by corporate insiders.
Monster Beverage Stock Performance
Shares of MNST stock traded up $0.01 during midday trading on Tuesday, hitting $57.84. 4,687,436 shares of the company were exchanged, compared to its average volume of 6,720,771. Monster Beverage Co. has a 52 week low of $43.32 and a 52 week high of $60.13. The firm has a market capitalization of $56.29 billion, a P/E ratio of 37.08, a PEG ratio of 2.28 and a beta of 0.71. The firm's 50 day moving average price is $51.51 and its two-hundred day moving average price is $52.18. The company has a debt-to-equity ratio of 0.13, a quick ratio of 2.51 and a current ratio of 3.13.
Monster Beverage (NASDAQ:MNST - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.40 by ($0.02). The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.80 billion. Monster Beverage had a return on equity of 23.31% and a net margin of 21.66%. As a group, equities research analysts anticipate that Monster Beverage Co. will post 1.62 earnings per share for the current year.
Analysts Set New Price Targets
Several analysts have issued reports on the company. UBS Group lifted their price target on Monster Beverage from $53.00 to $57.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Needham & Company LLC reaffirmed a "hold" rating on shares of Monster Beverage in a research note on Friday, February 28th. Morgan Stanley boosted their price objective on shares of Monster Beverage from $55.00 to $60.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. BNP Paribas decreased their target price on shares of Monster Beverage from $46.00 to $45.00 and set an "underperform" rating for the company in a research report on Thursday, December 19th. Finally, Citigroup boosted their price target on shares of Monster Beverage from $62.00 to $64.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $55.83.
Read Our Latest Stock Analysis on MNST
Monster Beverage Profile
(
Free Report)
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other.
Recommended Stories

Before you consider Monster Beverage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monster Beverage wasn't on the list.
While Monster Beverage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.